Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Avalo Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +1 vs. Q3 2022
- Shares held
- 5.55M
- +927 (0.0%) vs. Q3 2022
- Total value
- $28.0M
- +$9.56M (+51.9%) vs. Q3 2022
- New holders
- 3
- 4 more added
- Sold out
- 2
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3,964,666 | $20.0M | 0.54% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 540,667 | $2.73M | 0.25% | −7,147−1.3% | Reduced |
| Point72 Asset Management, L.P. | 500,737 | $2.52M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 222,073 | $1.12M | 0.00% | +910.0% | Added |
| BlackRock Inc. | 103,229 | $520.3K | 0.00% | −185−0.2% | Reduced |
| Geode Capital Management, LLC | 51,332 | $261.0K | 0.00% | −88−0.2% | Reduced |
| Millennium Management LLC | 43,193 | $220.0K | 0.00% | −7,819−15.3% | Reduced |
| Goldman Sachs Group Inc | 33,108 | $166.9K | 0.00% | −2,536−7.1% | Reduced |
| State Street Corp | 25,643 | $130.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 18,671 | $95.0K | 0.00% | +18,671 | New |
| Assenagon Asset Management S.A. | 15,646 | $79.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 12,425 | $62.6K | 0.00% | +826+7.1% | Added |
| Northern Trust Corp | 10,855 | $54.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,177 | $31.1K | 0.00% | −583−8.6% | Reduced |
| Meeder Asset Management Inc | 1,507 | $7.59K | 0.00% | +1+0.1% | Added |
| Royal Bank of Canada | 416 | $2.00K | 0.00% | +416 | New |
| TCI Wealth Advisors, Inc. | 251 | $1.26K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 183 | $931 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 131 | $660 | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 27 | $136 | 0.00% | +27 | New |
| FMR LLC | 13 | $66 | 0.00% | −22−62.9% | Reduced |
| Bank of America Corp | 10 | $50 | 0.00% | +6+150.0% | Added |
| Newbridge Financial Services Group, Inc. | 10 | $50 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 6 | $30 | 0.00% | 00.0% | Unchanged |
| Kistler-Tiffany Companies, LLC | 2 | $10 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 86 | $0 | 0.00% | −13−13.1% | Reduced |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −717−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −1−100.0% | Sold out |